First Trust Advisors
KRSA

First Trust Advisors’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

First Trust Advisors’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-227
Closed -$187K – 2349
2020
Q2 		$187K Buy
227
+19
+9% +$1.59K ﹤0.01% 2268
2020
Q1 		$77K Sell
208
-41
-16% -$2.92K ﹤0.01% 2311
2019
Q4 		$95K Sell
249
-4
-2% -$374 ﹤0.01% 2363
2019
Q3 		$430K Buy
+253
New +$54.6K ﹤0.01% 2178

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors's KRSA Position: Q3 2020 in Review

First Trust Advisors sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2020, closing a stake of 227 shares — an estimated $187K sold.

First Trust Advisors first reported a position in KRSA in Q3 2019 and held it in 4 quarters. The position peaked at $430K in Q3 2019. 69 funds tracked by Wall St. Rank hold KRSA as of Q3 2020.

  • First Trust Advisors reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • First Trust Advisors sold 227 Korsana Biosciences, Inc. Common Stock shares in Q3 2020, an estimated $187K.
  • First Trust Advisors first reported a position in Korsana Biosciences, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
  • First Trust Advisors's Korsana Biosciences, Inc. Common Stock position peaked at $430K in Q3 2019.
  • 69 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2020.

Based on First Trust Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.